XTLB
Xtl Biopharmaceuticals·NASDAQ
--
--(--)
--
--(--)
XTLB fundamentals
During H1 2025, Xtl Biopharmaceuticals (XTLB) reported revenue of 517.00K, a YoY change of 0.00%. Net income was -5.50M, a YoY change of -2411.42%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
FY,2015 | FY,2016 | 9M,2017 | FY,2017 | 9M,2018 | FY,2018 | FY,2019 | Q1,2020 | H1,2020 | 9M,2020 | FY,2020 | Q1,2021 | H1,2021 | 9M,2021 | FY,2021 | Q1,2022 | H1,2022 | 9M,2022 | FY,2022 | Q1,2023 | H1,2023 | 9M,2023 | FY,2023 | Q1,2024 | H1,2024 | 9M,2024 | FY,2024 | H1,2025 | TTM |
|---|
Start Date | Jan 1, 2015 | Jan 1, 2016 | Jan 1, 2017 | Jan 1, 2017 | Jan 1, 2018 | Jan 1, 2018 | Jan 1, 2019 | Jan 1, 2020 | Jan 1, 2020 | Jan 1, 2020 | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2021 | Jan 1, 2021 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2023 | Jan 1, 2023 | Jan 1, 2023 | Jan 1, 2023 | Jan 1, 2024 | Jan 1, 2024 | Jan 1, 2024 | Jan 1, 2024 | Jan 1, 2025 | -- |
End Date | Dec 31, 2015 | Dec 31, 2016 | Sep 30, 2017 | Dec 31, 2017 | Sep 30, 2018 | Dec 31, 2018 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Jun 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 162.00K -- | 451.00K -- | 517.00K -- | 968.00K -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | 0 -- | 162.00K -- | 451.00K -- | 517.00K -- | 968.00K -- |
Cost of Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 116.00K -- | 448.00K -- | 2.77M -- | 3.22M -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | 0 -- | 116.00K -- | 448.00K -- | 2.77M -- | 3.22M -- |
Gross Profit | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | 0 -- | 46.00K -- | 3.00K -- | -2.26M -- | -2.25M -- |
Operating Expenses | 3.61M -- | 2.56M -29.08% | 960.00K -- | 1.25M -51.35% | 572.00K -40.42% | 793.00K -36.36% | 842.00K +6.18% | 257.00K -- | 474.00K -- | 691.00K -- | 948.00K +12.59% | 232.00K -9.73% | 535.00K +12.87% | 745.00K +7.81% | 1.03M +8.76% | 249.00K +7.33% | 451.00K -15.70% | 655.00K -12.08% | 880.00K -14.65% | 251.00K +0.80% | 414.00K -8.20% | 565.00K -13.74% | 765.00K -13.07% | 175.00K -30.28% | 596.00K +43.96% | 1.41M +148.85% | 2.17M +184.31% | 5.35M +797.48% | 6.93M -- |
Selling, General and Administrative Expenses | 1.42M -- | 1.27M -10.50% | 913.00K -- | 1.20M -5.28% | 543.00K -40.53% | 755.00K -37.24% | 807.00K +6.89% | 254.00K -- | 460.00K -- | 665.00K -- | 910.00K +12.76% | 220.00K -13.39% | 517.00K +12.39% | 721.00K +8.42% | 1.00M +10.00% | 243.00K +10.45% | 430.00K -16.83% | 631.00K -12.48% | 850.00K -15.08% | 238.00K -2.06% | 395.00K -8.14% | 540.00K -14.42% | 734.00K -13.65% | 169.00K -28.99% | 584.00K +47.85% | 1.34M +148.15% | 2.08M +182.97% | 1.91M +227.40% | 3.40M -- |
Selling and Marketing Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | 0 -- | 284.00K -- | 487.00K -- | 1.07M -- | 1.55M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 807.00K -- | -- -- | -- -- | -- -- | 910.00K +12.76% | -- -- | -- -- | -- -- | 1.00M +10.00% | -- -- | -- -- | -- -- | 850.00K -15.08% | -- -- | -- -- | 540.00K -- | 734.00K -13.65% | -- -- | 584.00K -- | 1.06M +95.56% | 1.59M +116.62% | 846.00K +44.86% | 1.85M -- |
Research and Development Expenses | 578.00K -- | 443.00K -23.36% | 47.00K -- | 43.00K -90.29% | 29.00K -38.30% | 38.00K -11.63% | 35.00K -7.89% | 3.00K -- | 14.00K -- | 26.00K -- | 38.00K +8.57% | 12.00K +300.00% | 18.00K +28.57% | 24.00K -7.69% | 30.00K -21.05% | 6.00K -50.00% | 21.00K +16.67% | 24.00K -- | 30.00K -- | 13.00K +116.67% | 19.00K -9.52% | 25.00K +4.17% | 31.00K +3.33% | 6.00K -53.85% | 12.00K -36.84% | 66.00K +164.00% | 98.00K +216.13% | 21.00K +75.00% | 107.00K -- |
Loss on Impairment of Other Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 3.19M -- | -- -- |
Other Operating Expenses | 1.61M -- | 848.00K -47.46% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 223.00K -- | -- -- |
Operating Income | -3.61M -- | -2.56M +29.08% | -960.00K -- | -1.25M +51.35% | -572.00K +40.42% | -793.00K +36.36% | -842.00K -6.18% | -257.00K -- | -474.00K -- | -691.00K -- | -948.00K -12.59% | -232.00K +9.73% | -535.00K -12.87% | -745.00K -7.81% | -1.03M -8.76% | -249.00K -7.33% | -451.00K +15.70% | -655.00K +12.08% | -880.00K +14.65% | -251.00K -0.80% | -414.00K +8.20% | -565.00K +13.74% | -765.00K +13.07% | -175.00K +30.28% | -596.00K -43.96% | -1.36M -140.71% | -2.17M -183.92% | -7.61M -1176.17% | -9.18M -- |
Non-Operating Income (Loss) | -11.00K -- | 16.00K +245.45% | 181.00K -- | 465.00K +2806.25% | 2.51M +1287.29% | 3.78M +712.69% | 79.00K -97.91% | 430.00K -- | -458.00K -- | -1.19M -- | -2.01M -2639.24% | 518.00K +20.47% | -330.00K +27.95% | -915.00K +22.91% | 1.47M +173.08% | 755.00K +45.75% | 672.00K +303.64% | 55.00K +106.01% | -468.00K -131.92% | -668.00K -188.48% | -869.00K -229.32% | -933.00K -1796.36% | -1.02M -117.31% | 660.00K +198.80% | 377.00K +143.38% | 588.00K +163.02% | 1.01M +199.80% | 1.89M +400.53% | 2.52M -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -477.00K -- | -- -- | -- -- | -878.00K -- | -1.02M -114.26% | -- -- | 0 -- | 678.00K +177.22% | 1.09M +206.95% | 1.93M -- | 3.02M -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | 436.00K -- | -- -- | 3.73M +754.82% | 79.00K -97.88% | 423.00K -- | -474.00K -- | -1.20M -- | -2.01M -2639.24% | 525.00K +24.11% | -321.00K +32.28% | -906.00K +24.69% | 1.47M +173.08% | 761.00K +44.95% | 684.00K +313.08% | 57.00K +106.29% | 9.00K -99.39% | -655.00K -186.07% | -833.00K -221.78% | -55.00K -196.49% | 5.00K -44.44% | 666.00K +201.68% | 377.00K +145.26% | -90.00K -63.64% | -78.00K -1660.00% | -43.00K -111.41% | -498.00K -- |
Net Interest Expense | 11.00K -- | -16.00K -245.45% | -181.00K -- | -29.00K -81.25% | -2.51M -1287.29% | -52.00K -79.31% | -- -- | -7.00K -- | -16.00K -- | -16.00K -- | -- -- | 7.00K +200.00% | 9.00K +156.25% | 9.00K +156.25% | -- -- | 6.00K -14.29% | 12.00K +33.33% | 2.00K -77.78% | -- -- | 13.00K +116.67% | 36.00K +200.00% | -- -- | -- -- | 6.00K -53.85% | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Expense | 15.00K -- | 7.00K -53.33% | 353.00K -- | 8.00K +14.29% | 30.00K -91.50% | 35.00K +337.50% | -- -- | -- -- | 9.00K -- | -- -- | -- -- | -- -- | 14.00K +55.56% | -- -- | -- -- | 9.00K -- | 20.00K +42.86% | 22.00K -- | -- -- | 25.00K +177.78% | 57.00K +185.00% | -- -- | -- -- | 16.00K -36.00% | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Income | 4.00K -- | 23.00K +475.00% | 534.00K -- | 37.00K +60.87% | 2.54M +375.84% | 87.00K +135.14% | -- -- | -- -- | 25.00K -- | -- -- | -- -- | -- -- | 5.00K -80.00% | -- -- | -- -- | 3.00K -- | 8.00K +60.00% | 20.00K -- | -- -- | 12.00K +300.00% | 21.00K +162.50% | -- -- | -- -- | 10.00K -16.67% | -- -- | -- -- | -- -- | -- -- | -- -- |
Pretax Income From Continuing Operations | -3.62M -- | -2.54M +29.73% | -779.00K -- | -781.00K +69.31% | 1.94M +348.91% | 2.99M +482.33% | -763.00K -125.55% | 173.00K -- | -932.00K -- | -1.88M -- | -2.95M -287.16% | 286.00K +65.32% | -865.00K +7.19% | -1.66M +11.61% | 435.00K +114.73% | 506.00K +76.92% | 221.00K +125.55% | -600.00K +63.86% | -1.35M -409.89% | -919.00K -281.62% | -1.28M -680.54% | -1.50M -149.67% | -1.78M -32.20% | 485.00K +152.77% | -219.00K +82.93% | -772.00K +48.46% | -1.16M +35.07% | -5.72M -2511.42% | -6.66M -- |
Income Tax Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -130.00K -- | -219.00K -- | -349.00K -- |
Income from Discontinued Operations | -689.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -4.31M -- | -2.54M +40.96% | -779.00K -- | -781.00K +69.31% | 1.94M +348.91% | 2.99M +482.33% | -763.00K -125.55% | 173.00K -- | -932.00K -- | -1.88M -- | -2.95M -287.16% | 286.00K +65.32% | -865.00K +7.19% | -1.66M +11.61% | 435.00K +114.73% | 506.00K +76.92% | 221.00K +125.55% | -600.00K +63.86% | -1.35M -409.89% | -919.00K -281.62% | -1.28M -680.54% | -1.50M -149.67% | -1.78M -32.20% | 485.00K +152.77% | -219.00K +82.93% | -772.00K +48.46% | -1.03M +42.37% | -5.50M -2411.42% | -6.31M -- |
Net Income Attributable to Minority Interests | 2.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Owners of the Company | -4.31M -- | -2.54M +40.99% | -779.00K -- | -781.00K +69.31% | 1.94M +348.91% | 2.99M +482.33% | -763.00K -125.55% | 173.00K -- | -932.00K -- | -1.88M -- | -2.95M -287.16% | 286.00K +65.32% | -865.00K +7.19% | -1.66M +11.61% | 435.00K +114.73% | 506.00K +76.92% | 221.00K +125.55% | -600.00K +63.86% | -1.35M -409.89% | -919.00K -281.62% | -1.28M -680.54% | -1.50M -149.67% | -1.78M -32.20% | 485.00K +152.77% | -219.00K +82.93% | -772.00K +48.46% | -1.03M +42.37% | -5.50M -2411.42% | -6.31M -- |
Net Income Attributable to Common Stockholders | -4.31M -- | -2.54M +40.99% | -779.00K -- | -781.00K +69.31% | 1.94M +348.91% | 2.99M +482.33% | -763.00K -125.55% | 173.00K -- | -932.00K -- | -1.88M -- | -2.95M -287.16% | 286.00K +65.32% | -865.00K +7.19% | -1.66M +11.61% | 435.00K +114.73% | 506.00K +76.92% | 221.00K +125.55% | -600.00K +63.86% | -1.35M -409.89% | -919.00K -281.62% | -1.28M -680.54% | -1.50M -149.67% | -1.78M -32.20% | 485.00K +152.77% | -219.00K +82.93% | -772.00K +48.46% | -1.03M +42.37% | -5.50M -2411.42% | -6.31M -- |
Other Comprehensive Income | -- -- | 163.00K -- | -97.00K -- | -116.00K -171.17% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -4.31M -- | -2.38M +44.75% | -876.00K -- | -897.00K +62.34% | 1.94M +321.35% | 2.99M +432.89% | -763.00K -125.55% | -- -- | -- -- | -- -- | -2.95M -287.16% | -- -- | -- -- | -- -- | 435.00K +114.73% | 506.00K -- | 221.00K -- | -600.00K -- | -1.35M -409.89% | -919.00K -281.62% | -1.28M -680.54% | -1.50M -149.67% | -1.78M -32.20% | 485.00K +152.77% | -219.00K +82.93% | -772.00K +48.46% | -1.03M +42.37% | -5.50M -2411.42% | -6.31M -- |
Total Comprehensive Income Attributable to Minority Interests | 2.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -4.31M -- | -2.38M +44.77% | -876.00K -- | -897.00K +62.34% | 1.94M +321.35% | 2.99M +432.89% | -763.00K -125.55% | -- -- | -- -- | -- -- | -2.95M -287.16% | -- -- | -- -- | -- -- | 435.00K +114.73% | 506.00K -- | 221.00K -- | -600.00K -- | -1.35M -409.89% | -919.00K -281.62% | -1.28M -680.54% | -1.50M -149.67% | -1.78M -32.20% | 485.00K +152.77% | -219.00K +82.93% | -772.00K +48.46% | -1.03M +42.37% | -5.50M -2411.42% | -6.31M -- |
Basic EPS | -0.02 -- | -0.01 +50.00% | 0 -- | 0 +100.00% | 0 -- | 0.01 -- | 0 -100.00% | 0 -- | 0 -- | 0 -- | -0.01 -- | 0 -- | 0 -- | 0 -- | 0 +100.00% | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | -0.01 -- | -0.01 -- |
Basic EPS from Continuing Operations | -0.01 -- | -0.01 -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -0.01 -- | -- -- | -- -- | 0 -- | 0 +100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | 0 -- | 0 -- | 0 -- | -0.01 -- | -0.01 -- |
Basic EPS from Discontinued Operations | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Diluted EPS | -0.02 -- | -0.01 +50.00% | 0 -- | 0 +100.00% | 0 -- | 0.01 -- | 0 -100.00% | 0 -- | 0 -- | 0 -- | -0.01 -- | 0 -- | 0 -- | 0 -- | 0 +100.00% | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | -0.01 -- | -0.01 -- |
Diluted EPS from Continuing Operations | -0.01 -- | -0.01 -- | 0 -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -0.01 -- | -- -- | -- -- | 0 -- | 0 +100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | 0 -- | 0 -- | 0 -- | -0.01 -- | -0.01 -- |
Diluted EPS from Discontinued Operations | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
You can ask Aime
What were the key takeaways from Xtl Biopharmaceuticals's earnings call?What is the market's earnings forecast for Xtl Biopharmaceuticals next quarter?What factors drove the changes in Xtl Biopharmaceuticals's revenue and profit?What is the revenue and EPS growth rate for Xtl Biopharmaceuticals year over year?What is Xtl Biopharmaceuticals's gross profit margin?What does Xtl Biopharmaceuticals do and what are its main business segments?What is Xtl Biopharmaceuticals's latest dividend and current dividend yield?What were the key takeaways from Xtl Biopharmaceuticals’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
